Miller DD - Search Results

1

Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.

Miller DD, McEvoy JP, Davis SM, Caroff SN, Saltz BL, Chakos MH, Swartz MS, Keefe RS, Rosenheck RA, Stroup TS, Lieberman JA. Miller DD, et al. Schizophr Res. 2005 Dec 1;80(1):33-43. doi: 10.1016/j.schres.2005.07.034. Epub 2005 Sep 19. Schizophr Res. 2005. PMID: 16171976 Clinical Trial.

2

Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.

Schultz SK, Miller DD, Arndt S, Ziebell S, Gupta S, Andreasen NC. Schultz SK, et al. Among authors: miller dd. Biol Psychiatry. 1995 Dec 1;38(11):713-9. doi: 10.1016/0006-3223(95)00082-8. Biol Psychiatry. 1995. PMID: 8580223 Clinical Trial.

3

Schizophrenia: its etiology and impact.

Miller DD. Miller DD. Pharmacotherapy. 1996 Jan-Feb;16(1 Pt 2):2-5. Pharmacotherapy. 1996. PMID: 8778683

4

The life course of schizophrenia: age and symptom dimensions.

Schultz SK, Miller DD, Oliver SE, Arndt S, Flaum M, Andreasen NC. Schultz SK, et al. Among authors: miller dd. Schizophr Res. 1997 Jan 17;23(1):15-23. doi: 10.1016/S0920-9964(96)00087-4. Schizophr Res. 1997. PMID: 9050124

5

Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.

Ho BC, Andreasen NC, Flaum M, Nopoulos P, Miller D. Ho BC, et al. Am J Psychiatry. 2000 May;157(5):808-15. doi: 10.1176/appi.ajp.157.5.808. Am J Psychiatry. 2000. PMID: 10784476

6

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.

Miller A, Hall CS, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Ereshefsky L, Essock SM, Finnerty M, Marder SR, Miller DD, McEvoy JP, Rush AJ, Saeed SA, Schooler NR, Shon SP, Stroup S, Tarin-Godoy B. Miller A, et al. Among authors: miller dd. J Clin Psychiatry. 2004 Apr;65(4):500-8. doi: 10.4088/jcp.v65n0408. J Clin Psychiatry. 2004. PMID: 15119912 Review.

7

Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment.

Bishop JR, Ellingrod VL, Moline J, Miller D. Bishop JR, et al. Schizophr Res. 2005 Sep 15;77(2-3):253-60. doi: 10.1016/j.schres.2005.04.001. Schizophr Res. 2005. PMID: 15913960

8

Clinicians' recognition of the metabolic adverse effects of antipsychotic medications.

Buckley PF, Miller DD, Singer B, Arena J, Stirewalt EM. Buckley PF, et al. Among authors: miller dd. Schizophr Res. 2005 Nov 15;79(2-3):281-8. doi: 10.1016/j.schres.2005.04.010. Epub 2005 Jun 20. Schizophr Res. 2005. PMID: 15964743

9

Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.

Swartz MS, Wagner HR, Swanson JW, Stroup TS, McEvoy JP, Canive JM, Miller DD, Reimherr F, McGee M, Khan A, Van Dorn R, Rosenheck RA, Lieberman JA. Swartz MS, et al. Among authors: miller dd. J Nerv Ment Dis. 2006 Mar;194(3):164-72. doi: 10.1097/01.nmd.0000202575.79453.6e. J Nerv Ment Dis. 2006. PMID: 16534433

10

Baseline neurocognitive deficits in the CATIE schizophrenia trial.

Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer HY, Green MF, Miller DD, Canive JM, Adler LW, Manschreck TC, Swartz M, Rosenheck R, Perkins DO, Walker TM, Stroup TS, McEvoy JP, Lieberman JA. Keefe RS, et al. Among authors: miller dd. Neuropsychopharmacology. 2006 Sep;31(9):2033-46. doi: 10.1038/sj.npp.1301072. Epub 2006 Apr 19. Neuropsychopharmacology. 2006. PMID: 16641947 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

841 results

Search Page

Filters